Metrion is co-organising and attending the 'Drug Discovery for Ion Channels XXII' Virtual satellite meeting. This is a collaborative meeting, organised alongside partners Nanion, Sophion, Fluxion and SB Drug Discovery. The final line-up of Speakers will be confirmed very shortly. The event will start at 8AM PST / 5PM CET, with exact timimgs of specific [...]
Metrion Biosciences and LifeArc further extend neuroscience-focused ion channel drug discovery collaboration Ongoing collaboration extended for another 12 months and successfully progresses into late stage hit-to-lead optimisation phase Cambridge and London, UK, 18 January 2021: Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, and LifeArc, a leading UK independent [...]
Metrion Scientist Dr Charlotte Hill explains how she first discovered the wonderful world of patch clamp electrophysiology and how she came to write the chapter "An Introduction to Patch Clamp Recording" alongside Dr Gary Stephens. This chapter is featured within the book "An Introduction to Patch Clamp Recording" edited by Dr Damian Bell and [...]
Metrion Biosciences are attending the Virtual Nanion User Meeting to be held on 12th to 16th October 2020. Metrion's CSO Dr Marc Rogers will be presenting a talk at the event on 14th October entitled: Development and validation of ASIC1a ligand-gated ion channel drug discovery assays on automated patch clamp platforms. Abstract: Whilst voltage-gated ion [...]
Metrion Biosciences look forward to attending, presenting posters and exhibiting at the Virtual Safety Pharmacology Society (SPS) Annual Meeting to be held from 14th to 17th September 2020. Metrion will be located at Booth # 400 in the exhibits hall for the duration of the virtual event. Our collaborative poster with Nanion Technologies will be [...]
Introducing Damian Bell: as a new member of the team at Metrion we are using an abridged version of an interview by Artem Kondratskyi for ionchannellibrary.com. A big thank you to Artem for sharing this interview and a quick plug for his website – we highly recommend it as an excellent resource for anyone [...]
Metrion Biosciences and International Scientific Consortium publish data and new recommendations for in vitro risk assessment of the cardiac safety of new medicines Part of the US FDA’s Comprehensive in vitro Proarrythmia Assay (CiPA) Initiative Cambridge, UK, 07 April 2020: Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today [...]
Metrion Biosciences and Nanion Technologies look forward to hosting their first collaborative webinar on Tuesday 28th April entitled: Validation and optimization of automated patch clamp voltage-gated Ca2+ channel assays. The webinar will feature Metrion's CSO Dr. Marc Rogers. Marc will outline the development, optimisation and validation of a range of voltage-gated Ca2+ channel assays on [...]
Metrion Biosciences and LifeArc extend ion channel drug discovery collaboration to accelerate neuroscience-focused research Initial twelve month collaboration successfully identifies hit compounds and progresses into hit-to-lead optimisation phase Cambridge and London, UK, 03 December 2019: Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, and LifeArc, a leading UK independent medical [...]
Thank you to the ELRIG Committee and to BioStrata for allowing us to share the below content on our website. The British Pharmacological Society (BPS) ran a special symposium at the ELRIG Drug Discovery 2019 conference yesterday, focused on the importance of targeting ion channels for drug discovery. As a unique platform to foster the [...]
